Variant report
Variant | nsv1055484 |
---|---|
Chromosome Location | chr19:21141787-21158134 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:83)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr19:21147595-21147600 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr19:21150502-21150834 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr19:21153810-21154256 | Hela-S3 | cervix: | n/a | n/a |
4 | CEBPB | chr19:21153717-21154132 | IMR90 | lung: | n/a | n/a |
5 | CEBPB | chr19:21153648-21154070 | A549 | lung: | n/a | n/a |
6 | CEBPB | chr19:21151165-21151573 | IMR90 | lung: | n/a | n/a |
7 | CEBPB | chr19:21150575-21150785 | IMR90 | lung: | n/a | n/a |
8 | CEBPB | chr19:21153393-21155054 | HepG2 | liver: | n/a | n/a |
9 | CEBPB | chr19:21150477-21150759 | A549 | lung: | n/a | n/a |
10 | CEBPB | chr19:21151053-21151339 | A549 | lung: | n/a | n/a |
11 | CEBPB | chr19:21152662-21152674 | HepG2 | liver: | n/a | n/a |
12 | CEBPB | chr19:21154510-21154909 | A549 | lung: | n/a | n/a |
13 | CEBPB | chr19:21151071-21151772 | HepG2 | liver: | n/a | n/a |
14 | CTCF | chr19:21148790-21148888 | ProgFib | skin: | n/a | n/a |
15 | CTCF | chr19:21147720-21147870 | HEK293 | kidney: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
16 | CTCF | chr19:21147833-21147954 | Kidney_OC | kidney: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
17 | CTCF | chr19:21147720-21147870 | GM12868 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
18 | CTCF | chr19:21147800-21147919 | GM19238 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
19 | CTCF | chr19:21147580-21147730 | NHEK | skin: | n/a | n/a |
20 | CTCF | chr19:21147655-21148024 | H1-hESC | embryonic stem cell: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
21 | CTCF | chr19:21147700-21147850 | SAEC | small airway: | n/a | n/a |
22 | CTCF | chr19:21147760-21147910 | AG09309 | skin: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
23 | CTCF | chr19:21145988-21146030 | Fibrobl | skin: | n/a | n/a |
24 | CTCF | chr19:21147773-21147995 | K562 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
25 | CTCF | chr19:21147780-21147930 | HMEC | breast: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
26 | CTCF | chr19:21147821-21147836 | MCF-7 | breast: | n/a | n/a |
27 | CTCF | chr19:21147840-21147990 | BE2_C | brain: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
28 | CTCF | chr19:21147783-21147919 | NHEK | skin: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
29 | CTCF | chr19:21147768-21147975 | H1-hESC | embryonic stem cell: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
30 | CTCF | chr19:21147797-21147919 | HepG2 | liver: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
31 | CTCF | chr19:21147780-21147930 | Hela-S3 | cervix: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
32 | CTCF | chr19:21147800-21147950 | GM12866 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
33 | CTCF | chr19:21147820-21147870 | Spleen_OC | spleen: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
34 | CTCF | chr19:21147747-21147872 | MCF-7 | breast: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
35 | CTCF | chr19:21147740-21147890 | BJ | skin: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
36 | CTCF | chr19:21147766-21147905 | K562 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
37 | CTCF | chr19:21147880-21148030 | NHEK | skin: | n/a | n/a |
38 | CTCF | chr19:21147718-21147726 | MCF-7 | breast: | n/a | n/a |
39 | CTCF | chr19:21147760-21147922 | K562 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
40 | CTCF | chr19:21147772-21147941 | Fibrobl | skin: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
41 | CTCF | chr19:21147780-21147930 | GM12874 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
42 | CTCF | chr19:21147760-21147910 | NHEK | skin: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
43 | CTCF | chr19:21147683-21148028 | H1-hESC | embryonic stem cell: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
44 | CTCF | chr19:21147761-21147932 | K562 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
45 | CTCF | chr19:21147820-21147970 | HBMEC | blood vessel: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
46 | CTCF | chr19:21147782-21147891 | MCF-7 | breast: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
47 | CTCF | chr19:21147800-21147950 | K562 | blood: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
48 | CTCF | chr19:21147760-21147910 | WERI-Rb-1 | eye: | n/a | chr19:21147851-21147869 chr19:21147853-21147866 |
49 | CTCF | chr19:21147843-21147858 | GM19240 | blood: | n/a | n/a |
50 | CTCF | chr19:21147801-21147820 | MCF-7 | breast: | n/a | n/a |
No data |
No data |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZNF85-1 | chr19:21155068-21155323 | ENSG00000268326.1 |
2 | lnc-ZNF626-5 | chr19:21154184-21154294 | NONHSAT063678 |
3 | lnc-ZNF626-5 | chr19:21154460-21154697 | NONHSAT063678 |
4 | lnc-ZNF85-1 | chr19:21155029-21155323 | XLOC_013005 |
5 | lnc-ZNF626-5 | chr19:21149318-21149428 | NONHSAT063678 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000269147 | TF binding region |
ENSG00000268326 | TF binding region |
KRT18P40 | TF binding region |
WNK1 | miRNA target sites |
OAZ1 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576145727 | chr19:21143402-21143403 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs73007376 | chr19:21143431-21143432 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs558647561 | chr19:21143467-21143468 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs572032214 | chr19:21143474-21143475 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs540641715 | chr19:21143520-21143521 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs190250738 | chr19:21143535-21143536 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs377607323 | chr19:21143541-21143542 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs193263701 | chr19:21143591-21143592 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs534247820 | chr19:21143592-21143593 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs35462458 | chr19:21143598-21143599 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs35506500 | chr19:21143606-21143607 | Inactive region | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs59841381 | chr19:21143625-21143626 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs56004027 | chr19:21143653-21143654 | Inactive region | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs150985999 | chr19:21144025-21144026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540974843 | chr19:21144039-21144040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs59633955 | chr19:21144056-21144057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534098388 | chr19:21144088-21144089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184125873 | chr19:21144090-21144091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543009261 | chr19:21144092-21144093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574131896 | chr19:21144105-21144106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188308282 | chr19:21144115-21144116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs576645330 | chr19:21144121-21144122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs55840212 | chr19:21144132-21144133 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs536965056 | chr19:21144133-21144134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs56373736 | chr19:21144143-21144144 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs56170000 | chr19:21144147-21144148 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs144326195 | chr19:21144156-21144157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181137596 | chr19:21144178-21144179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530145213 | chr19:21144209-21144210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549892982 | chr19:21144263-21144264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs545457151 | chr19:21144273-21144274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147762030 | chr19:21144322-21144323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532278606 | chr19:21144341-21144342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374664766 | chr19:21144352-21144353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185581479 | chr19:21144353-21144354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534502532 | chr19:21144385-21144386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554294271 | chr19:21144395-21144396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567790994 | chr19:21144397-21144398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs188630361 | chr19:21144408-21144409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs181521990 | chr19:21144423-21144424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs55988249 | chr19:21144459-21144460 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs60115932 | chr19:21144523-21144524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368124387 | chr19:21144524-21144525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs187002519 | chr19:21144568-21144569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559114255 | chr19:21144572-21144573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs55715113 | chr19:21144577-21144578 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs56356813 | chr19:21144614-21144615 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs56210506 | chr19:21144630-21144631 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs145434651 | chr19:21144649-21144650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs56033918 | chr19:21144664-21144665 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chordoma | 18071362 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Cervical cancer | 21063398 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Lung cancer | 18438408 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Colorectal cancer | 20459617 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Schizophrenia | 20967226 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:21144000-21144200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr19:21144200-21147600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr19:21145200-21146200 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr19:21147600-21147800 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr19:21147600-21147800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr19:21148800-21151800 | Enhancers | Primary B cells from peripheral blood | blood |
7 | chr19:21151200-21151600 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr19:21151600-21152000 | Enhancers | Pancreas | Pancrea |
9 | chr19:21152000-21152400 | Weak transcription | Pancreas | Pancrea |
10 | chr19:21152400-21153400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr19:21152400-21155000 | Enhancers | Pancreas | Pancrea |